Combination of hgf inhibitor and egf inhibitor to treat cancer
OwnerJohn Laterra, Bachchu Lal +1inventors
InventorsJohn Laterra, Bachchu Lal, Kyung Jin Kim
Life of this patent
Estimating the term…
Abstract
The present invention is directed toward a method of treating cancer by administering to a patient an inhibitor of Hepatocyte Growth Factor and an inhibitor of, e.g., Epidermal Growth Factor.
Claims23
A method of treating cancer in a patient comprising administering to the patient a first agent that is an inhibitor of Hepatocyte Growth Factor (HGF) in combination with a second agent that is an inhibitor of a cellular signaling pathway other than the HGF/cMet pathway.
A method of treating cancer in a patient comprising administering to the patient an inhibitor of Hepatocyte Growth Factor (HGF) in combination with an inhibitor of Epidermal Growth Factor (EGF).
A composition or kit comprising a humanized L2G7 antibody and drug selected from the group consisting of cetuximab, panitumumab, elotinib and gefitib.
Dependencies are inferred from the claim text.